Polymorphisms in the presenilin 1 and presenilin 2 genes and risk for sporadic Alzheimer's disease

被引:11
作者
Combarros, O [1 ]
Alvarez-Arcaya, A
Oterino, A
Berciano, J
Delgado-Rodríguez, M
Peña, N
Fernández-Viadero, C
Pérez-López, JL
Setién, S
Carvajal, A
机构
[1] Marques de Valdecilla Univ Hosp, Neurol Serv, Santander 39008, Spain
[2] Univ Cantabria, Fac Med, Dept Prevent Med & Publ Hlth, Santander, Spain
[3] RTE Santander, Consejeria Sanidad, Cantabria, Spain
[4] Sierrallana Hosp, Serv Neurol, Torrelavega 39300, Cantabria, Spain
关键词
Alzheimer's disease; presenilin; 1; 2; apolipoprotein E; polymorphism; odds ratio;
D O I
10.1016/S0022-510X(99)00254-3
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We examined the possible involvement of polymorphisms of the presenilin I (PS1) and presenilin 2 (PS2) genes in the risk for sporadic Alzheimer's disease (AD), either through an independent effect or through interaction with the existing apolipoprotein E (ApoE) risk, in 211 AD cases and 188 age-matched control subjects. No significant differences were obtained in any of the comparisons relating the effect of the PS1 and PS2 polymorphisms; thus, these polymorphisms do not appear to be sufficient risk factors by themselves for sporadic AD. Although the ApoE epsilon 4 genotype is the only definite predictor of risk, homozygosity for either the 1 allele of the PS1 or the C allele of the PS2 genes may increase the risk conferred by the presence of an ApoE epsilon 4 allele. Additionally, combination of PS1/11 and PS2/CC genotypes might have a small synergistic effect on the risk for AD. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:88 / 91
页数:4
相关论文
共 23 条
[1]   Presenilin-I, presenilin-II, and VLDL-R associations in early onset Alzheimer's disease [J].
Brookes, AJ ;
Howell, WM ;
Woodburn, K ;
Johnstone, EC ;
Carothers, A .
LANCET, 1997, 350 (9074) :336-337
[2]  
Combarros O, 1998, ACTA NEUROL SCAND, V97, P68
[3]   Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population based study of presenile Alzheimer disease [J].
Cruts, M ;
van Duijn, CM ;
Backhovens, H ;
Van den Broeck, M ;
Wehnert, A ;
Serneels, S ;
Sherrington, R ;
Hutton, M ;
Hardy, J ;
St George-Hyslop, PH ;
Hofman, A ;
Van Broeckhoven, C .
HUMAN MOLECULAR GENETICS, 1998, 7 (01) :43-51
[4]  
Cruts M, 1998, HUM MUTAT, V11, P183, DOI 10.1002/(SICI)1098-1004(1998)11:3<183::AID-HUMU1>3.3.CO
[5]  
2-M
[6]   The genotype 2/2 of the presenilin-1 polymorphism is decreased in Spanish early-onset Alzheimer's disease [J].
Ezquerra, M ;
Blesa, R ;
Tolosa, E ;
Pousa, SL ;
Aguilar, M ;
Pena, J ;
Van Broeckhoven, C ;
Ballesta, F ;
Oliva, R .
NEUROSCIENCE LETTERS, 1997, 227 (03) :201-204
[7]   Alzheimer's disease -: A technical KO of amyloid-β peptide [J].
Haass, C ;
Selkoe, DJ .
NATURE, 1998, 391 (6665) :339-340
[8]  
Higuchi S, 1996, LANCET, V347, P1186
[9]   Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes [J].
Holcomb, L ;
Gordon, MN ;
McGowan, E ;
Yu, X ;
Benkovic, S ;
Jantzen, P ;
Wright, K ;
Saad, I ;
Mueller, R ;
Morgan, D ;
Sanders, S ;
Zehr, C ;
O'Campo, K ;
Hardy, J ;
Prada, CM ;
Eckman, C ;
Younkin, S ;
Hsiao, K ;
Duff, K .
NATURE MEDICINE, 1998, 4 (01) :97-100
[10]   Presenilin-1 polymorphism in patients with Alzheimer's disease, vascular dementia and alcohol-associated dementia in Japanese population [J].
Isoe, K ;
Urakami, K ;
Ji, Y ;
Adachi, Y ;
Nakashima, K .
ACTA NEUROLOGICA SCANDINAVICA, 1996, 94 (05) :326-328